report fiscal adjust ep
consensu expect higher estim lower-than-
expect adjust tax rate drove upsid versu forecast help
off-set weaker adjust oper margin expans anticip
ste fiscal revenu increas year-over-year million
consensu expect million similar
estim million quarter report constant currenc
organ growth slightli forecast driven
strength appli steril constant currenc
healthcar specialti servic constant currenc notabl
healthcar equip organ growth roughli weaker
expect appear sale time issu compani
healthcar equip order backlog year-over-year
million end fiscal
adjust ste result adopt new account
standard relat classif retir benefit plan cost
over-year estim account
chang account bp delta versu adjust oper
margin forecast beyond increas spend ste healthcar
divis invest instrument repair support growth start-up
expens initi outsourc steril reprocess facil
expect begin contribut revenu fiscal contribut
modest adjust oper margin expans quarter
ste combin order backlog healthcar life scienc product
increas year-over-year million end fiscal
addit sale time issu think ste strong new product launch
activ healthcar equip includ earli launch v-pro
max endo also aid backlog posit
maintain guidanc adjust ep constant
currenc growth free cash flow million compani
announc outsourc steril process agreement sterilm
end begin august chang reduc ste
revenu approxim million littl impact adjust net
incom previous assum ste guidanc
adjust ep forecast remain
total debt total asset
encourag strong start fiscal year well
favor equip backlog posit continu believ ste organ
growth acceler rang think could
contribut modest multipl expans current level reiter
buy rate increas price target
import pleas read disclosur disclaim page report
report fiscal adjust ep consensu expect higher
estim lower-than-expect adjust tax rate drove upsid versu forecast help
off-set weaker adjust oper margin expans anticip
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens incom incom tax incom extra margin extra incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset result reflect adopt new account standard relat classif retir benefit plan cost chang increas sg expens incom million million million respect andlow adjust oper incom adjust oper margin million bp respect fiscal estim previous assum impact account chang fiscal revenu increas year-over-year million consensu expect
million similar estim million quarter report constant currenc
organ growth slightli forecast led appli steril
healthcar specialti servic currenc growth modestli lower model
growth posit fiscal similar forecast
quarter healthcar consum servic revenu increas mid-single-digit rate organ
healthcar capit grew roughli exclud currenc chang notabl healthcar equip
steri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research organ growth weaker expect appear sale time issu compani
healthcar equip order backlog year-over-year million end fiscal
addit sale time issu think ste strong new product launch activ healthcar equip
includ earli launch v-pro max endo also aid backlog posit total
maintain expect mid-single-digit healthcar capit organ growth think
forecast reason given compani backlog posit easi year-over-year comparison fiscal
fiscal ste life scienc busi post organ growth estim
similar healthcar divis life scienc capit sale littl weak fiscal given easi year-
over-year comparison reflect sale time issu life scienc consum servic revenu grew
rang comparison becom difficult life scienc equip later year
believ sale time issu provid off-set enabl compani post least low-single-digit
organ growth categori also think life scienc consum servic organ growth
stronger subsequ quarter compani begin see benefit recur revenu stream
creat strong life scienc capit sale high-teen year-over-year
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim aid black diamond video acquisitionsteri plclife scienc divis organ growth analysi compani report northcoast research ste appli steril technolog ast busi achiev organ growth fiscal
well forecast compani point strong medic devic procedur volum contribut
factor growth think capac expans favor price also help subsequ
quarter ste ast organ growth hurt end outsourc steril process agreement
sterilm occur begin august total chang expect reduc ste
revenu million littl impact net incom moreov end sterilm
agreement expect ste ast organ growth declin posit mid-single-digit rang fiscal
posit low-single-digit rang fiscal
ste healthcar specialti servic busi achiev report constant currenc organ growth
fiscal forecast believ market growth instrument repair track
mid-single-digit rang keep pace market legaci synergi health outsourc steril
process busi also appear perform well benefit significantli initi outsourc
steril process contract start fiscal note expect million fiscal outsourc
steril process revenu northwel sever addit custom annual revenu
account expect ramp million time
adjust ste result adopt new account standard relat classif
retir benefit plan cost compani fiscal adjust oper margin increas bp year-over-
year estim account chang account bp delta
versu adjust oper margin forecast beyond increas spend ste healthcar
divis invest instrument repair support growth start-up expens initi outsourc
steril reprocess facil expect begin contribut revenu fiscal contribut
modest adjust oper margin expans quarter
reiter guidanc adjust ep constant currenc growth free cash
flow million also maintain adjust ep forecast
summari encourag strong start fiscal year well favor equip
backlog posit continu believ ste organ growth acceler rang
think could contribut modest multipl expans current level reiter buy
rate increas price target
steri plchealthcar specialti servic divis organ growth analysissourc compani report northcoast research plcadjust oper margin healthcar life appli steril healthcar specialti fiscal exclud corpor expensesourc compani report northcoast research
ri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest expens interest net expens incom incom incom tax minor net incom net margin net net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim result reflect adopt new account standard relat classif retir benefit plan cost chang reduc adjust oper incom million increas net incom similar amount roughli oper incom chang cog approxim sg expens assum similar split disclosur
